Author Archives
Dorkina Myrick, MD, PhD, JD, LLM, MPP (Oxon) is an experienced physician, scientific researcher, and administrator. She has provided program leadership for national and international academic medical centers and biomedical research institutions. During her tenure as a Department of Health and Human Services Brookings Institution Legislative Fellow in the Senate and the House of Representatives, she advised congressional staff and managed legislative issues in health care and biomedical research.
Views expressed on this blog are those of the author and those of commenters who respond to articles posted on the blog. The blog offers neither medical nor legal advice.
-
Scientists Develop a Rapid, Low-Cost, User-Friendly Way to Detect Deadly Drug-Resistant Infections
Dorkina Myrick, MD, PhD “Some experts say we are moving back to the pre-antibiotic era. No. This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is virtually dry. A post-antibiotic era means, in effect, an… Read More ›
-
Health Alert – November: Increasing Awareness of Diabetes Risk in Ethnic Communities
Various ethnic groups experience higher rates of diabetes incidence and prevalence than the general population. Learn more about the risks and ways to help prevent the disease from the statistics here (Click on each infographic to enlarge): Mexican-Americans Have a… Read More ›
-
November is Lung Cancer Awareness Month
-
Markey Wins!!! Thank You Massachusetts Voters!
-
Ed Markey: The Right Choice for Medicine, Science, the Senate, and America
Voter Canvassing in Cambridge, Massachusetts – Saturday, June 22, 2013 Image Credit: Dorkina Myrick, M.D., Ph.D. Today is election day in Massachusetts. Voters head to the polls to select either Democratic Congressman Ed Markey or Republican candidate Gabriel Gomez in a race… Read More ›
-
Father’s Day and Men’s Health Week (June 10-16, 2013)
-
The Twitterverse…DNA Patents Denied, Oral Sex and HPV, and EHRs: Top Tweets for June 7-14, 2013
Thursday, June 13, 2013: Finally! A ruling in Association for Molecular Pathology v. Myriad Genetics, Inc. et al. Biotechnology company Myriad Genetics claimed exclusive rights to patents for ovarian and breast cancer DNA that it had isolated and genetically altered. However,… Read More ›
-
Tough Sell: Marketing the Health Insurance Exchanges
PolicyKina excerpt from “To Market, to Market: Federal Funding for Health Exchange Implementation“: “The Health Insurance Marketplace (a.k.a. Health Insurance Exchange) will be open for enrollment beginning October 1, 2013, and people in the United States will be able to… Read More ›
-
Medical Student Loan Profits and a Lifetime of Debt
PolicyKina Excerpt: “Mortgaging Your Life: The Hidden Costs of Medical School Loans.” Image Credit: Dreamstime.com/Eti Swinford “I recently tweeted about a blog post, ‘The High Cost of Profiting from Student Loans,’ that discusses the tens of billions of dollars in profits that the… Read More ›


